Clinical trial
Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type…
NCT00285233 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00285233 |
|---|---|
| Title | Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes |
| Official title | An Open-label Pilot Study of Delayed Mycophenolate Mofetil Instead of Tacrolimus Combined With Anti-thymocyte Globulin, Daclizumab, Etanercept, and Sirolimus in Single-donor, Solitary Islet Allograft Recipients With Type 1 Diabetes |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | Roche Pharma AG Industry Juvenile Diabetes Research Foundation |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes, Hypoglycemia |
| Intervention type | Biological |
| Interventions | Allogeneic islets of Langerhans transplant |
| Enrollment | 8 |
| Start date | Sep 1, 2000 |
| Primary completion | Sep 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Feb 1, 2006 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: